Couchoud Cécile, Labeeuw Michel, Moranne Olivier, Allot Vincent, Esnault Vincent, Frimat Luc, Stengel Bénédicte
REIN Registry, Agence de la biomédecine, 1 Avenue du Stade de France, 93212 Saint Denis La Plaine Cedex, France.
Nephrol Dial Transplant. 2009 May;24(5):1553-61. doi: 10.1093/ndt/gfn698. Epub 2008 Dec 18.
The aim of this study was to develop and validate a prognostic score for 6-month mortality in elderly patients starting dialysis for end-stage renal disease.
Using data from the French Rein registry, we developed a prognostic score in a training sample of 2500 patients aged 75 years or older who started dialysis between 2002 and 2006, which we validated in a similar sample of 1642 patients. Multivariate logistic regression with 500 bootstrap samples allowed us to select risk factors from 19 demographic and baseline clinical variables.
The overall 6-month mortality was 19%. Age was not associated with early mortality. Nine risk factors were selected and points assigned for the score were as follows: body mass index <18.5 kg/m2 (2 points), diabetes (1), congestive heart failure stages III to IV (2), peripheral vascular disease stages III to IV (2), dysrhythmia (1), active malignancy (1), severe behavioural disorder (2), total dependency for transfers (3) and unplanned dialysis (2). The median score was 2. Mortality rates ranged from 8% in the lowest risk group (0 point) to 70% in the highest risk group (> or =9 points) and 17% in the median group (2 points). Seventeen percent of all deaths occurred after withdrawal from dialysis, ranging from 0% for a score of 0-1 to 15% for a score of 7 or higher.
This simple clinical score effectively predicts short-term prognosis among elderly patients starting dialysis. It should help to illuminate clinical decision making, but cannot be used to withhold dialysis. It ought to only be used by nephrologists to facilitate the discussion with the patients and their families.
本研究旨在开发并验证一种用于预测老年终末期肾病患者开始透析后6个月死亡率的预后评分系统。
利用法国Rein注册研究的数据,我们在2500例年龄≥75岁、于2002年至2006年间开始透析的患者训练样本中开发了一种预后评分系统,并在1642例类似患者样本中进行了验证。通过对500个自抽样样本进行多变量逻辑回归,我们从19个人口统计学和基线临床变量中筛选出了危险因素。
总体6个月死亡率为19%。年龄与早期死亡率无关。筛选出9个危险因素,并为评分系统赋予相应分值如下:体重指数<18.5 kg/m²(2分)、糖尿病(1分)、Ⅲ至Ⅳ级充血性心力衰竭(2分)、Ⅲ至Ⅳ级外周血管疾病(2分)、心律失常(1分)、活动性恶性肿瘤(1分)、严重行为障碍(2分)、完全依赖他人协助转移(3分)以及非计划性透析(2分)。中位评分为2分。死亡率在最低风险组(0分)为8%,最高风险组(≥9分)为70%,中位组(2分)为17%。所有死亡病例中有17%发生在停止透析后,评分0 - 1分的患者这一比例为0%,评分7分及以上的患者为15%。
这种简单的临床评分系统能有效预测老年透析起始患者的短期预后。它有助于指导临床决策,但不能用于拒绝透析治疗。该评分系统仅应由肾病学家使用,以促进与患者及其家属的沟通。